Sub Banner Image

Pfizer to Cut Medicaid Drug Prices in Deal With Trump: WaPo

Markets

Michelle Fay Cortez

·

September 30, 2025

·

Bloomberg

Pfizer Inc. will sell drugs at lower prices to the US Medicaid insurance program as part of a deal with President Donald Trump to advance his “most favored nations” agenda, according to a report in the Washington Post.

More from

Bloomberg

More

Markets

Articles

Trending News

Enjoy premium content in your inbox.

You're in! Check your email to learn more.
Oops! Something went wrong while submitting the form.